Rigin 200mg (Palmitoyl Tetrapeptide-7) — The Gold-Standard Anti-Aging Peptide Ingredient

Rigin 200mg, standardized to Palmitoyl Tetrapeptide-7, is a premium cosmetic active designed for professional formulators, dermatologists, and skincare brands seeking clinically validated anti-aging performance. Backed by over two decades of peptide research, Rigin 200mg delivers measurable improvements in skin firmness, elasticity, and inflammatory balance — making it one of the most powerful signal peptides available in the cosmetic ingredient market today.

Product Overview: What Is Rigin 200mg?

Rigin 200mg is the trade name for a lipopeptide complex built around Palmitoyl Tetrapeptide-7, a synthetic tetrapeptide composed of four amino acids — glycine, glutamine, asparagine, and arginine — covalently bonded to a palmitoyl (C16 fatty acid) chain. This lipid attachment dramatically enhances the peptide’s ability to penetrate the stratum corneum, allowing active delivery to the dermal layer where collagen synthesis and cellular repair take place.

Each gram of Rigin contains 200 mg of the active peptide complex, offering formulators a consistent, high-potency raw material that integrates easily into a broad spectrum of topical delivery systems. It is water-dispersible and compatible with standard cosmetic excipients.

Key Technical Specifications

• INCI Name: Palmitoyl Tetrapeptide-7
• CAS Number: 1253637-40-1
• Peptide Sequence: Pal-Gly-Gln-Pro-Arg
• Active Concentration: 200 mg per gram (20%)
• Appearance: Off-white to pale yellow powder or aqueous solution

• Solubility: Water-dispersible; soluble in propylene glycol blends
• Recommended Use Level: 1–10% in final formulation (based on supplier dilution)
• pH Stability: 4.5–7.0
• Preservation: Store at 2–8°C, away from direct light

Mechanism of Action: How Palmitoyl Tetrapeptide-7 Works

Understanding Rigin 200mg begins with understanding the molecular language of skin aging. As skin matures, the extracellular matrix (ECM) degrades due to chronic low-grade inflammation, oxidative stress, and declining growth factor activity. Palmitoyl Tetrapeptide-7 intervenes at multiple points within this cascade.

1. IGF-1 (Insulin-like Growth Factor-1) Modulation

Palmitoyl Tetrapeptide-7 is a selective antagonist of Interleukin-6 (IL-6) stimulated IGF-1 release. While IGF-1 has anabolic effects early in life, excessive IGF-1 signaling in aging skin contributes to glycation, matrix metalloproteinase (MMP) upregulation, and collagen cross-linking. By modulating this pathway, Rigin 200mg helps restore a more youthful cellular signaling environment, encouraging healthier fibroblast activity and reduced ECM breakdown.

2. Interleukin-6 (IL-6) Suppression

IL-6 is a pro-inflammatory cytokine central to the concept of “inflammaging” — the chronic subclinical inflammation that accelerates visible skin aging. Palmitoyl Tetrapeptide-7 has demonstrated in vitro inhibitory activity against IL-6 secretion, reducing the inflammatory burden on dermal fibroblasts and keratinocytes. Lower IL-6 levels translate directly to reduced collagen degradation, improved barrier function, and a calmer skin tone.

3. Collagen and Elastin Stimulation

Through its downstream effects on fibroblast signaling, Rigin 200mg promotes the de novo synthesis of collagen type I and III, as well as fibronectin and elastin. These structural proteins are responsible for skin’s tensile strength and bounce. Regular topical application in well-formulated vehicles results in measurably firmer, more resilient skin over an 8–12 week period.

Key Benefits of Rigin 200mg in Cosmetic Formulations

Rigin 200mg is positioned as a multifunctional anti-aging ingredient, offering benefits that address both structural and biological aspects of skin aging:

Visible Anti-Wrinkle Activity

Clinical and consumer studies on formulations containing Palmitoyl Tetrapeptide-7 have shown statistically significant reductions in the depth and length of expression lines, particularly in the periorbital and nasolabial regions, after 4 to 8 weeks of consistent use.

Skin Firming and Lifting Effect

By rebuilding the collagen and elastin networks in the dermis, Rigin 200mg contributes to a visible tightening and lifting effect. Cutometer measurements in clinical studies demonstrate improvements in skin firmness (R0) and elasticity (R2) parameters.

Anti-Inflammatory and Calming Properties

The IL-6 inhibitory mechanism gives Rigin 200mg powerful anti-inflammatory credentials, making it suitable for sensitive skin formulations, post-procedure skincare, and products designed to address redness, puffiness, or reactive skin conditions.

Improved Skin Texture and Radiance

By supporting keratinocyte turnover and reducing the impact of inflammaging on the epidermal layer, Rigin 200mg contributes to improved skin surface texture, evenness, and luminosity over time.

Synergy with Complementary Actives

Rigin 200mg performs exceptionally well in combination with other signal peptides such as Matrixyl 3000 (Palmitoyl Tripeptide-1 / Palmitoyl Tetrapeptide-7 blend), retinoids, niacinamide, hyaluronic acid, and antioxidant complexes. This synergistic potential makes it a versatile anchor ingredient for premium multi-active formulations.

Formulation Guidance and Application Recommendations

Rigin 200mg is designed for professional incorporation into a wide range of topical products. The following guidance is intended for qualified formulators operating within appropriate regulatory frameworks.

Recommended Product Types

• Anti-aging day and night creams
• Eye contour serums and firming eye creams
• Peptide-rich facial serums and boosters
• Sheet masks and bio-cellulose delivery systems
• Post-procedure recovery balms and soothing gels
• Neck and décolleté firming treatments
• Premium body firming lotions

Formulation Tips

Add Rigin 200mg to the aqueous phase of emulsions at temperatures below 40°C to preserve peptide integrity. Avoid prolonged exposure to temperatures above 50°C. The ingredient is compatible with most emulsifiers, humectants, and preservative systems at standard use concentrations. It is not recommended for high-pH (above 7.5) or highly alkaline formulations.

When combining with retinoids or exfoliating acids, ensure the final formulation pH is carefully managed. Rigin 200mg is stable in buffered systems between pH 4.5 and 7.0. Always conduct challenge testing and compatibility studies in your specific formulation matrix before commercialization.

Regulatory Status and Safety Profile

Global Regulatory Compliance

Palmitoyl Tetrapeptide-7, the active component of Rigin 200mg, is an approved cosmetic ingredient listed in the EU Cosmetics Inventory, the US CosIng database, and recognized under relevant regulatory frameworks in major markets including Canada, Australia, Japan, South Korea, and China (NMPA registration required). It is not classified as a drug or pharmaceutical and is intended exclusively for external topical cosmetic use.

Safety and Tolerability

Palmitoyl Tetrapeptide-7 has an established safety profile supported by repeat insult patch testing (RIPT), skin sensitization studies, and dermatologist-supervised clinical assessments. It is non-irritating at recommended use concentrations and has been shown to be well-tolerated by sensitive skin types, including those with rosacea-prone or post-procedure skin conditions.

Ethical and Quality Standards

Rigin 200mg is produced under GMP-compliant conditions. Certificates of Analysis (CoA), Safety Data Sheets (SDS), and supporting technical documentation are available upon request for qualified customers. Cruelty-free and vegan-compatible grades are available.

Why Choose Rigin 200mg for Your Formulation?

In a marketplace crowded with cosmetic actives making unsubstantiated claims, Rigin 200mg stands apart for three core reasons: scientific rigor, formulation versatility, and measurable consumer results. Its dual mechanism — targeting both the inflammatory pathway (IL-6) and the structural pathway (collagen/elastin biosynthesis) — provides a more comprehensive anti-aging effect than single-mechanism actives.

For brands seeking to position products at the premium or clinical end of the market, inclusion of Rigin 200mg provides compelling on-label claims, credible scientific storytelling, and the consumer-perceptible results that drive repurchase and loyalty.

• Clinically researched active ingredient with dual mechanism of action
• Compatible with a broad range of formulation systems and complementary actives
• Suitable for sensitive, mature, and post-procedure skin types
• Supports substantiated anti-aging on-pack claims
• Backed by transparent technical documentation and safety data

Ordering, Availability, and Technical Support

Rigin 200mg (Palmitoyl Tetrapeptide-7) is available in research-scale quantities (1g, 5g) through to commercial bulk supply, subject to qualification and MOQ requirements. Our technical team is available to support your formulation development process, from initial compatibility testing through to finished product stability programs.

Contact our ingredient sales team for pricing, lead times, sample requests, and full technical data packages including CoA, SDS, stability data, and in vitro/in vivo study summaries. Private label and white-label formulation services incorporating Rigin 200mg are also available on request.